Solid Biosciences Inc. (SLDB) stock forecast and price target
Price $6.84 · data as of November 13, 2026
12-month price target
Average target$18.71
Upside / downside+173.6%
Analysts14
ConsensusStrong buy
Low $11.00Average $18.71High $26.00
Gold marker: average target · white marker: today’s price ($6.84)
Analyst ratings
Strong buy 5Buy 10Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.61 | +19.1% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.59 | +1.4% | $2M |
| Next quarter ends December 31, 2026 | $-0.38 | +28.2% | $0 |
| Quarter after ends March 31, 2027 | $-0.41 | — | $0 |
Consensus of the analysts covering Solid Biosciences, updated daily. In the last 30 days 7 estimates were raised and 0 lowered.
Frequently asked questions
What is the Solid Biosciences stock price target?
The average 12-month target from 14 analysts is $18.71, 173.6% above the current price of $6.84 Targets range from $11.00 to $26.00.
Is Solid Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (5 strong buy, 10 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Solid Biosciences expected to earn?
Analysts expect EPS of $-1.61 for the fiscal year ending December 31, 2026 and $-1.59 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.